We are looking for 2–17 year olds to join a Crohn’s disease (CD) clinical research study to help us discover more about treating moderate to severe Crohn’s disease. If you are looking for a potential new treatment option for moderate to severe Crohn’s disease or moderately to severely active ulcerative colitis (including associated symptoms such as tiredness, iron deficiency, rectal pain, frequent fevers and/or liver disease), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years old may be eligible to take part.
Your child may be eligible to take part in the IBD research studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
See if your child qualifies.
